Konstantin Huhn

Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study

Konstantin Huhn, Antonios Bayas, Sebastian Doerck et al. · Journal of Neurology · 2018 · 35 citations

Rheumatology, Ms Patients, Clinical Trials +5

Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study

Wolf A. Lagrèze, Sebastian Küchlin, Gabriele Ihorst et al. · The Lancet Neurology · 2021 · 29 citations

Ophthalmology, Eye Health, Placebo-controlled Study +2

Baseline Magnetic Resonance Imaging of the Optic Nerve Provides Limited Predictive Information on Short-Term Recovery after Acute Optic Neuritis

Sebastian Berg, Iris Kaschka, Kathrin S. Utz et al. · PLoS ONE · 2015 · 25 citations · Full text

Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?

De-Hyung Lee, Silvia Seubert, Konstantin Huhn et al. · PLoS ONE · 2017 · 25 citations · Full text

Inflammation, Fingolimod Effects, Astroglial Glutamate Transporters +13

Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients

Victoria Prockl, Florian T. Nickel, Kathrin S. Utz et al. · Journal of the Neurological Sciences · 2020 · 24 citations

Medicine, Immunology, Clinical Neurology +6